Inflammatix scores BARDA contract for infection tests November 14, 2019 -- Startup Inflammatix is set to get $6 million from the U.S. Biomedical Advanced Research and Development Authority (BARDA) and up to $72 million as part of a cost-sharing contract to develop its rapid point-of-care tests for infections.
Hologic airs validating data for Aptima STI test November 12, 2019 -- A study demonstrating the effectiveness of Hologic's Aptima assay for the increasingly common sexually transmitted infection (STI) Mycoplasma genitalium has been published in the Journal of Clinical Microbiology.
Thermo Fisher teams with Owlstone on breath tests November 7, 2019 -- Thermo Fisher Scientific is working with Owlstone Medical to develop noninvasive breath sample tests in a collaboration that will include the discovery and validation of new biomarkers for the earlier detection of disease.
Vela wins FDA clearance for HIV-1 genotyping NGS assay November 6, 2019 -- Vela Diagnostics USA has garnered U.S. Food and Drug Administration (FDA) marketing approval for its Sentosa SQ HIV-1 genotyping assay, a test designed to detect HIV-1 drug resistance mutations using next-generation sequencing (NGS) technology.
Qiagen TB blood test headed for wider global use October 31, 2019 -- Qiagen's Quantiferon-TB Gold Plus blood test for detecting latent tuberculosis (TB) made the list of diagnostics in the international Stop TB Partnership Global Drug Facility product catalog.